wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37652075-AB162435-37B0-4ACC-AAC5-C0794084F102
Q37652075-AB162435-37B0-4ACC-AAC5-C0794084F102
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37652075-AB162435-37B0-4ACC-AAC5-C0794084F102
Construction and expression of a human/mouse chimeric CD19 monoclonal antibody: Successful modification of a murine IgM to a chimeric IgG.
P2860
Q37652075-AB162435-37B0-4ACC-AAC5-C0794084F102
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37652075-AB162435-37B0-4ACC-AAC5-C0794084F102
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5f60fc56e3d6ed7c3144d1f8981ea7e0989973b0
P2860
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia